Comparison of chemometrics strategies for the spectroscopic monitoring of active pharmaceutical ingredients in chemical reactions

被引:5
|
作者
Thiel, Michel [1 ,4 ]
Sauwen, Nicolas [2 ]
Khamiakova, Tastiana [1 ]
Maes, Tor [3 ]
Govaerts, Bernadette [4 ]
机构
[1] Janssen Pharmaceut, Mfg & Appl Stat, Turnhoutseweg 30, B-2340 Beerse, Belgium
[2] Open Analyt NV, Jupiterstr 20, B-2600 Antwerp, Belgium
[3] Janssen Pharmaceut, API Small Mol Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium
[4] UCLouvain, Inst Stat Biostat & Actuarial Sci ISBA, Louvain Inst Data Anal & Modeling Econ & Stat LID, Voie Roman Pays 20,Bte L1-04-01, B-1348 Louvain La Neuve, Belgium
关键词
Process monitoring; Spectroscopy; NMF; MCR; PCA; PLS; PAT;
D O I
10.1016/j.chemolab.2021.104273
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The Process Analytical Technology (PAT) initiative promoted by the Food and Drug Administration (FDA) encourages pharmaceutical companies to increase the use of new analytical technologies to perform constant monitoring of the critical quality attributes (CQA), allowing a better understanding and a better control of the process. This paper presents a practical framework based on different dimension-reduction methods as well as calibration methods aimed at following over time chemical experiments organized in batches. To illustrate it, this paper uses pharmaceutical data collected in a research and development context towards industrial production. This methodological framework aims to reach two objectives. The first objective is to visualize and interpret in real time, or off-line, the kinetics of chemical reactions using the following dimension-reduction methods: principal component analysis (PCA), non-negative matrix factorization (NMF) and multivariate curve resolution (MCR). The results show that, due to their additional constraints, NMF and MCR allow a better interpretability of chemical reactions than PCA with a comparable quality of fit. Moreover, eventough NMF and MCR come from different fields, their algorithms share many similarities and produce close results. The second objective is to predict chemical component concentrations over time. For this second objective, the partial least squares regression (PLSR) is used in a one-step approach and compared with a two-step approach combining multivariate regression with PCA, NMF or MCR. The results show that spectra or scores obtained from unsupervised approaches PCA, NMF or MCR can be used to predict concentrations of the main chemical compounds continuously over all the time of the reaction with a good precision and with a gain of interpretability. For both objectives, possible model validation indices are also discussed including a leave-one-batch-out approach.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Chemical Assembly Systems: Layered Control for Divergent, Continuous, Multistep Syntheses of Active Pharmaceutical Ingredients
    Ghislieri, Diego
    Gilmore, Kerry
    Seeberger, Peter H.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (02) : 678 - 682
  • [22] Intelligent Miniplatform for On-Site Monitoring of Water Samples and Pharmaceutical Production of Ointments Based on Betamethasone and Gentamicin as Active Pharmaceutical Ingredients
    Tuchiu, Bianca-Maria
    Stefan-van Staden, Raluca-Ioana
    van Staden, Jacobus Frederick
    JOURNAL OF THE ELECTROCHEMICAL SOCIETY, 2024, 171 (06)
  • [23] Hydrotropy and co-solvency: Sustainable strategies for enhancing solubility of poorly soluble pharmaceutical active ingredients
    El Hamd, Mohamed A.
    Obaydo, Reem H.
    Nashed, Dania
    El-Maghrabey, Mahmoud
    Lotfy, Hayam M.
    TALANTA OPEN, 2025, 11
  • [24] Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients
    Ponting, David J.
    Dobo, Krista L.
    Kenyon, Michelle O.
    Kalgutkar, Amit S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (23) : 15584 - 15607
  • [25] Raman and Terahertz Spectroscopic Characterization of Solid-state Cocrystal Formation within Specific Active Pharmaceutical Ingredients
    Du, Yong
    Xue, Jiadan
    Hong, Zhi
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (38) : 4829 - 4846
  • [26] Review/Preview: Prodrug Ionic Liquids Combining the Prodrug and Ionic Liquid Strategies to Active Pharmaceutical Ingredients
    Cojocaru, O. Andreea
    Shamshina, Julia L.
    Rogers, Robin D.
    CHIMICA OGGI-CHEMISTRY TODAY, 2013, 31 (05) : 24 - 28
  • [27] Combined high-throughput and mechanistic approach to the development of catalytic reactions for the synthesis of active pharmaceutical ingredients
    Leitch, David
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [28] Preparation of Amorphous Solid Dispersions by Cryomilling: Chemical and Physical Concerns Related to Active Pharmaceutical Ingredients and Carriers
    Pas, Timothy
    Bergonzi, Alessandra
    Michiels, Emiel
    Rousseau, Frederic
    Schymkowitz, Joost
    Koekoekx, Robin
    Clasen, Christian
    Vergauwen, Bjorn
    Van den Mooter, Guy
    MOLECULAR PHARMACEUTICS, 2020, 17 (03) : 1001 - 1013
  • [29] Near-infrared spectroscopic identification and quantification of active pharmaceutical ingredients in closed capsules: a feasibility study for pediatric doses
    Mainka, David L.
    Link, Andreas
    ANALYTICAL METHODS, 2019, 11 (40) : 5185 - 5194
  • [30] A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies
    Duarte, Ana Rita C.
    Ferreira, Ana Sofia D.
    Barreiros, Susana
    Cabrita, Eurico
    Reis, Rui L.
    Paiva, Alexandre
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 114 : 296 - 304